# Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair

> **NCT01203644** · PHASE2 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 76 (actual)

## Conditions studied

- Inguinal Hernia

## Interventions

- **DRUG:** SKY0402
- **DRUG:** Bupivacaine HCl

## Key facts

- **NCT ID:** NCT01203644
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-01
- **Final completion:** 2006-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203644, "Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01203644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*